SEOUL, March 12 (Korea Bizwire) — A growing number of South Koreans are undergoing cancer screenings, with government-recommended participation rates reaching 70.2% last year, marking a 3.8 percentage-point increase from 2024, according to a new report by the National Cancer Center. The study, which surveyed 4,500 individuals without a prior cancer diagnosis, examined participation rates [...]
SEOUL, March 12 (Korea Bizwire) — A novel treatment using high-voltage electrical pulses to destroy cancer cells has shown promising results for patients with inoperable pancreatic cancer, according to research from Severance Hospital in Seoul. The study, led by Kim Man-deuk and Kwon Joon-ho from the hospital’s radiology department, demonstrated improved survival rates using an advanced [...]
SEOUL, Jan. 17 (Korea Bizwire) — A groundbreaking study from Samsung Medical Center has revealed that cancer patients who maintain or begin regular exercise after diagnosis can reduce their risk of cardiac events like heart attacks by 20%, offering new hope for managing cardiovascular complications associated with cancer treatment. The research, led by Shin Dongwook of [...]
DAEJEON, Dec. 23 (Korea Bizwire) – In a significant advance for cancer treatment, researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed a novel technique that transforms colon cancer cells into normal-like cells without destroying them, the institute announced on December 22. The research team, led by professor Cho Kwang-hyun from the [...]
SEOUL, Dec. 18 (Korea Bizwire) – A breast cancer screening AI solution is proving to be a valuable assistant to medical professionals, helping to identify tumors that might otherwise go undetected, according to a physician at Yongin Severance Hospital. In an interview on December 16, Dr. Lee Si-eun, a radiologist at the hospital, described how artificial [...]
DAEJEON, Dec. 12 (Korea Bizwire) – South Korean researchers have developed a new messenger RNA (mRNA) treatment that can replicate the effects of cancer cell therapy within the body, the Korea Advanced Institute of Science and Technology (KAIST) announced on December 11. Led by Professor Park Ji-ho from the Department of Bio and Brain Engineering, the [...]
SEOUL, Oct. 4 (Korea Bizwire) — Cancer, heart disease and pneumonia were among the key causes of death for South Koreans in 2023, data showed Friday, with suicide remaining the top factor among those in their 30s and younger. Last year, the total number of deaths reported in the country came to 352,511, down 5.5 [...]
SEOUL, Sept. 19 (Korea Bizwire) – In a recent evaluation of the world’s best cancer hospitals, three South Korean medical institutions have secured positions within the top 10, marking a significant achievement for the country’s healthcare system. According to Newsweek’s “World’s Best Specialized Hospitals” rankings released on September 18, Samsung Medical Center, Asan Medical Center, and [...]
SEOUL, Sept. 9 (Korea Bizwire) — The number of cancer surgeries decreased significantly in the first five months after a junior doctors’ strike began in February, data from the Health Insurance Review and Assessment Service (HIRA) showed Monday. Between February and June, the number of patients who underwent cancer surgeries at upper-class general hospitals nationwide [...]
SPRING, Texas, Jul. 8 (Korea Bizwire) — Io Therapeutics, Inc., presented today results from studies done in breast, lung, colorectal, and prostate cancer models with the company’s newest anti-cancer compound IRX5010, an agonist of retinoic acid nuclear receptor gamma which was discovered in the company’s oncology drug program. The presentation titled “RAR Gamma Agonist Compounds [...]